Articles

Towards a true assessment of the prima facie validity of (European) patents

Towards a true assessment of the prima facie validity of (European) patents

Towards a true assessment of the prima facie validity of (European) patents

02.10.2014 BE law

In an apparent move away from its own recent case-law, the Belgian Court of Cassation (“Cour de Cassation” / “Hof van Cassatie”) has confirmed the necessity of a true assessment of the prima facie validity of (European) patents within the framework of Belgian preliminary injunction and descriptive seizure (“saisie-contrefaçon” / “beslag inzake namaak”) procedures.

The decision of 12 September 2014 may herald a new era in patent litigation in Belgium, which is for most long overdue.

In its decision, the Court stated that lower courts may not simply set aside:

  1. a foreign decision nullifying the corresponding national part of a European patent, and 
  2. a decision on the merits nullifying a patent, when such decision has not yet entered into force (because of an appeal procedure with suspensive effect which has been initiated against such decision),

as irrelevant because (a) not issued in relation to the Belgian part of the same European patent, and (b) not yet entered into force, respectively.

The foregoing opens the door to a true assessment of the prima facie validity of (European) patents. Indeed, with its decision the Court seems to distance itself from its earlier – and relatively recent – decisions of 5 January 2012 and 24 June 2013, which have been interpreted by some as creating a quasi-insurmountable presumption of validity of (European) patents in Belgium, even in cases as in (1) and (2) above.

Team

Related news

02.09.2019 BE law
Stibbe verwelkomt Philippe Campolini als partner in praktijk intellectuele eigendom

Inside Stibbe - Brussel, 2 september 2019 – Stibbe is verheugd om Philippe Campolini als nieuwe vennoot in zijn Brussels kantoor te verwelkomen. Philippe is gespecialiseerd in het intellectueel eigendomsrecht en de life sciences sector. Zijn komst versterkt Stibbe’s toonaangevende IP-praktijk en beantwoordt aan nieuwe marktbehoeften in dit rechtsdomein. Philippe vervoegt Stibbe op 2 september 2019 en zal nauw samenwerken met IP-vennoot Ignace Vernimme.

Read more

02.09.2019 BE law
Philippe Campolini rejoint l’éminente pratique IP de Stibbe en qualité d’associé

Inside Stibbe - Bruxelles, 2 septembre 2019 – Le cabinet de Stibbe Bruxelles est ravi d’accueillir Philippe Campolini, avocat spécialisé en droit de la propriété intellectuelle et des sciences de la vie, en tant que nouvel associé. Son arrivée vient non seulement renforcer la pratique de référence du cabinet en la matière, mais également répondre à l’évolution des besoins du marché. Philippe rejoint le cabinet Stibbe le 2 septembre 2019. Il travaillera en étroite collaboration avec Ignace Vernimme, associé spécialisé en droit de la propriété intellectuelle.

Read more

02.09.2019 BE law
Philippe Campolini joins Stibbe’s leading IP practice as partner

Inside Stibbe - Brussels, 2 September 2019 – Stibbe is delighted to welcome IP lawyer and life sciences specialist Philippe Campolini as new partner in its Brussels office. Stibbe’s hiring of Philippe reinforces the firm’s leading intellectual property practice and responds to developing market needs. Philippe joins Stibbe on 2 September 2019 and will team up with IP law partner Ignace Vernimme.

Read more

21.03.2019 EU law
Ignace Vernimme, Floris ten Have and Manuel Campolini are speakers during the Legal Affairs Conference.

Speaking slot - Ignace Vernimme, IP Partner at Stibbe Brussels, moderates a roundtable discussion on 'second medical use patents'. Manuel Campolini, of-counsel at Stibbe Brussels, co-moderates this session. Floris ten Have, Competition and Regulation Partner at Stibbe Amsterdam, chairs a session on opportunities and challenges for biosimilar medicine developers.

Read more

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring